Skip to content

Inpatient Multimodal Path to RecOVEry

Inpatient Multimodal Path to RecOVEry

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03303664
Acronym
IMPROVE
Enrollment
0
Registered
2017-10-06
Start date
2017-07-11
Completion date
2018-02-26
Last updated
2022-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use, Pain

Keywords

opioid, inpatient, pain, multimodal

Brief summary

The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a menu of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management.

Detailed description

The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a menu of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management. This intervention will be implemented throughout CHS hospitals, using a stepped wedge design to guide rollout. The initial pilot will be conducted in the trauma inpatient units at Carolinas Medical Center. All patients admitted to the two primary trauma units (11A and 11 Tower) during the pilot study period will be included in the evaluation.

Interventions

OTHERIMPROVE Protocol

Comprehensive pain management protocol

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients treated in facility as inpatient during the study period will be included in the analysis.

Exclusion criteria

* Patients not admitted to facility during the study period will be excluded from the analysis.

Design outcomes

Primary

MeasureTime frameDescription
Use of Opioid Overdose Reversal TreatmentPatient's entire length of stay in the hospital, up to 3 monthsIncidence of administration of opioid reversal agent

Secondary

MeasureTime frameDescription
PainPatient's entire length of stay in the hospital, up to 3 monthsAverage daily pain scores (VAS)
Oversedation without naloxonePatient's entire length of stay in the hospital, up to 3 monthsIncidence of patient oversedation (Pasero \> 2 or associated diagnosis code)
Multimodal TherapyPatient's entire length of stay in the hospital, up to 3 monthsPercentage of patients receiving multimodal pain management
Average Daily MMEPatient's entire length of stay in the hospital, up to 3 monthsMorphine Milligram Equivalent Dosing for Opioid Medications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026